Antibiotic Management of Infectious Colitis (Evidence‑Based Recommendations)

General Management

• Supportive care without antibiotics is recommended for most adult infectious colitis because the majority of cases are self‑limited and antimicrobial benefits are outweighed by risks such as prolonged bacterial shedding and antimicrobial resistance. 1

Diagnostic Indicators Guiding Therapy

• Bloody diarrhea accompanied by fever, abdominal pain, or vomiting suggests an invasive/inflammatory pathogen (e.g., Salmonella, Campylobacter, Clostridioides difficile, Shigella, STEC). 1
• Bloody diarrhea with minimal or absent fever raises suspicion for Shiga‑toxin–producing E. coli (STEC) infection. 1

Situations in Which Antibiotics Should Be Avoided

• Antibiotics must be avoided for STEC O157 or any STEC producing Shiga toxin 2 because evidence shows they cause harm. 1
• Routine antimicrobial therapy is not recommended for uncomplicated Salmonella gastroenteritis, as it prolongs bacterial shedding without clear benefit. 1
• For Campylobacter infection, antibiotics provide only a modest benefit (≈ 1‑day shorter illness) and promote quinolone‑resistant shedding; therefore, they are generally discouraged. 1
• When STEC is part of the differential diagnosis, antibiotics should be withheld because the Shiga‑toxin profile is often unknown and no clear therapeutic advantage exists, especially in bloody diarrhea with low‑grade or absent fever. 1

Situations in Which Antibiotics Are Indicated

• Severe infections or immunocompromised hosts represent primary exceptions where the benefits of antimicrobial therapy outweigh the risks. 1
• Empiric fluoroquinolone therapy has been shown in randomized controlled trials to reduce symptom duration by roughly one day, but rising resistance limits its current applicability. 1
• Early antimicrobial treatment of enteric (typhoid) fever improves outcomes, decreasing rates of intestinal perforation and mortality compared with the pre‑antibiotic era. 1

Clostridioides difficile Considerations

• The incidence of C. difficile infection has doubled since 2001 and can mimic other forms of infectious colitis. 1
• Community‑acquired C. difficile cases are increasingly observed in patients with minimal prior antibiotic exposure. 1
• Concomitant antimicrobial use during C. difficile infection reduces cure rates and increases relapse rates. 1

Supportive Care

• Most inflammatory infectious diarrhea episodes are self‑limited; management focuses on preventing dehydration and malnutrition and monitoring for severe complications such as toxic megacolon. 1

Antibiotic Use in Infectious Colitis – Evidence‑Based Recommendations

General Recommendations (IDSA 2017)

• The 2017 IDSA guideline states that most inflammatory infectious diarrheal episodes are self‑limited; antibiotics shorten symptom duration by only about one day on average in randomized controlled trials, offering modest benefit. 2

Pathogen‑Specific Guidance

Salmonella

• For uncomplicated Salmonella gastroenteritis, routine antimicrobial therapy prolongs bacterial shedding and provides no clear clinical advantage, so antibiotics are not recommended. 2

Campylobacter

• Antibiotic treatment of uncomplicated Campylobacter infection yields a modest reduction of illness duration (~1 day) and is most effective only when administered very early; otherwise the disease is self‑limited. 2

Shigella (non‑severe)

• Although Shigella is generally responsive to antibiotics, many non‑severe cases are mild and resolve without antimicrobial therapy. 2

Shiga toxin‑producing E. coli (STEC)

• Antibiotics must be avoided for STEC infections (including O157 and any strain producing Shiga toxin 2) because evidence demonstrates they cause harm; this is a strong, absolute contraindication. 2

Indications for Antibiotic Therapy

Severe Disease or Immunocompromised Hosts

• Antibiotics are indicated for patients with severe infection (high fever, marked abdominal pain, systemic toxicity, or bacteremia) or for immunocompromised individuals, as the benefits outweigh the risks in these groups. 2

Enteric (Typhoid) Fever

• Early antimicrobial treatment of enteric fever improves outcomes, reducing intestinal perforation rates and mortality. 2

Clostridioides difficile Infection

• Specific therapy (e.g., vancomycin or fidaxomicin) is required for C. difficile infection; concurrent use of other antibiotics decreases cure rates and increases relapse. 2

Diagnostic Considerations

Role of Multiplex PCR Testing

• Multiplex PCR platforms enable rapid identification of enteric pathogens, potentially allowing earlier targeted antimicrobial therapy when an indication exists. 2